Kintor Pharmaceutical (HKSE:09939) Days Inventory : 2,606.42 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Kintor Pharmaceutical Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Kintor Pharmaceutical's Average Total Inventories for the six months ended in Dec. 2023 was HK$659.66 Mil. Kintor Pharmaceutical's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$46.19 Mil. Hence, Kintor Pharmaceutical's Days Inventory for the six months ended in Dec. 2023 was 2,606.42.

The historical rank and industry rank for Kintor Pharmaceutical's Days Inventory or its related term are showing as below:

HKSE:09939' s Days Inventory Range Over the Past 10 Years
Min: 5325.69 Med: 5325.69 Max: 5382.89
Current: 5382.89

During the past 6 years, Kintor Pharmaceutical's highest Days Inventory was 5382.89. The lowest was 5325.69. And the median was 5325.69.

HKSE:09939's Days Inventory is ranked worse than
97.86% of 654 companies
in the Biotechnology industry
Industry Median: 192.63 vs HKSE:09939: 5382.89

Kintor Pharmaceutical's Days Inventory increased from Dec. 2022 (0.00) to Dec. 2023 (2,606.42). It might indicate that Kintor Pharmaceutical's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Kintor Pharmaceutical's Inventory Turnover for the six months ended in Dec. 2023 was 0.07.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Kintor Pharmaceutical Days Inventory Historical Data

The historical data trend for Kintor Pharmaceutical's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kintor Pharmaceutical Days Inventory Chart

Kintor Pharmaceutical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

5,325.69

Kintor Pharmaceutical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial						-	-	-	-	2,606.42

Competitive Comparison of Kintor Pharmaceutical's Days Inventory

For the Biotechnology subindustry, Kintor Pharmaceutical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kintor Pharmaceutical's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kintor Pharmaceutical's Days Inventory distribution charts can be found below:

* The bar in red indicates where Kintor Pharmaceutical's Days Inventory falls into.

Kintor Pharmaceutical Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Kintor Pharmaceutical's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (673.941	+	0)	/	1 )	/	46.189	*	365
=	673.941					/	46.189	*	365
=	5,325.69

Kintor Pharmaceutical's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (659.66	+	0)	/	1 )	/	46.189	*	365 / 2
=	659.66					/	46.189	*	365 / 2
=	2,606.42

Kintor Pharmaceutical (HKSE:09939) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Kintor Pharmaceutical's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	46.189	/	659.66
	=	0.07

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Kintor Pharmaceutical's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	659.66	/	0
	=

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Kintor Pharmaceutical Days Inventory Related Terms

Thank you for viewing the detailed overview of Kintor Pharmaceutical's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Kintor Pharmaceutical (HKSE:09939) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kintor Pharmaceutical Ltd (HKSE:09939) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

KNTPF:USA

Address

No. 20 Songbei Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215123

Website

https://www.kintor.com.cn

Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China focused on the proprietary R&D of drugs for cancers and other AR-related diseases. The company's drug candidate, Pruxelutamide, is a drug undergoing phase III clinical trials in China and phase III clinical trials in the United States for mCRPC as well as clinical trials for breast cancer. Its pipeline of seven drug candidates includes Pruxelutamide (GT0918), Pyrilutamide (KX-826), ALK-1 (GT90001), Detorsertib (GT0486), Hedgehog/SMO Inhibitor (GT1708F), PD-L1/TGF-ß (GT90008), and AR-PROTAC Compound (GT20029). It operates in a single segment focusing on the research and development of medical products.

Executives

Tong Youzhi	2101 Beneficial owner
Kt International Investment Limited	2101 Beneficial owner
Guo Chuangxing	2201 Interest of corporation controlled by you
Kg Development Limited	2101 Beneficial owner
Nomura Holdings, Inc.	2201 Interest of corporation controlled by you
Tong Youzhi	2201 Interest of corporation controlled by you
Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si	2101 Beneficial owner
Zhu Hai Ge Li Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Sovereign Fiduciaries (hong Kong) Limited
Kiya Company Limited
Lian Xiang Kong Gu Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Nan Ming You Xian Gong Si	2201 Interest of corporation controlled by you
Shi Xian You Xian Gong Si	2101 Beneficial owner

Kintor Pharmaceutical (HKSE:09939) Headlines

No Headlines